|
Post by promann on May 12, 2017 6:26:06 GMT -5
As much as I would like to think it's for Afrezza I see no evidence of it in the new job opening at Amgen in Dubai
|
|
|
Post by mnholdem on May 12, 2017 6:47:52 GMT -5
Are you serious? Afrezza particles are nothing compared to smoking. In fact, most of the car exhaust that you breathe into your lungs (yes, you even breathe it through your car vents) or dust and other crud in a major city is far more harmful. let me try again: Afrezza box say no smoker + UAE have lots smoker = not good sales Mnkd = unhappy investor Oh, I did get your point but you may also be forgetting that restrictions imposed by the FDA are for drugs marketed in the USA. The FDA has no jurisdiction in foreign countries, so countries where 80% of the male population are smokers may have a different viewpoint.
Besides the label simply says that Afrezza is "not recommended for patients who smoke." It does not say that it's contraindicated as it is for patients with chronic lung disease, COPD or asthma.
|
|
|
Post by cyn on May 12, 2017 9:01:23 GMT -5
While middle eastern countries have a serious problem of diabetes, they have an even bigger problem with smoking. UAE is 30% smokers and for "young people" its upwards of 40%. Not only is the percentage very high, its growing higher in recent years. Rates of lung cancer are growing. Likely there is a population of ex-smokers too. Mnkd making another strategic blunder going into the middle east IMO. Good place to initiate and recruit for new clinical study to determine safeness and effectiveness among smokers.
|
|
|
Post by slugworth008 on May 12, 2017 14:10:41 GMT -5
Are you serious? Afrezza particles are nothing compared to smoking. In fact, most of the car exhaust that you breathe into your lungs (yes, you even breathe it through your car vents) or dust and other crud in a major city is far more harmful. let me try again: Afrezza box say no smoker + UAE have lots smoker = not good sales Mnkd = unhappy investor Let me try also: UAE figures if you smoke = inhaling insulin can't hurt you Afrezza is awesome = UAE doesn't care what the box says = JMHO
|
|
|
Post by sportsrancho on May 12, 2017 14:42:05 GMT -5
This is weird, but out of the six people I know personally using Afrezza. Two are kids. Two smoke. One has COPD and one has asthma.
|
|
|
Post by peppy on May 12, 2017 16:59:37 GMT -5
This is weird, but out of the six people I know personally using Afrezza. Two are kids. Two smoke. One has COPD and one has asthma. oh good, real people.
|
|
|
Post by kuka on May 13, 2017 2:31:25 GMT -5
Remember folks International Sales are IMPOSSIBLE without an International PARTNER .... it is and has always been AMGEN
You can thank me later this week
|
|
|
Post by promann on May 13, 2017 5:13:21 GMT -5
Remember folks International Sales are IMPOSSIBLE without an International PARTNER .... it is and has always been AMGEN You can thank me later this week I believe you! There is just one thing I don't understand.. The shorts must and I mean have to know this too, why are they still in this war as if they still think they can bankrupt MNKD? Will they ever give up? When the news hits about partnering in other countries will they cover? Something tells me NO. Unfortunately they are a virus that will only have one cure, a pill of large script numbers to profitability. Then they will have no choice but to release there grip on this stock. Last week was very exciting and I went all in on Monday and Tuesday's premarket at .80 and 1.00 buys I'm holding till the shorts are gone and this reaches its full potential. The sky's the limit. Good luck.
|
|
|
Post by sportsrancho on May 13, 2017 6:11:45 GMT -5
Remember folks International Sales are IMPOSSIBLE without an International PARTNER .... it is and has always been AMGEN You can thank me later this week I believe you! There is just one thing I don't understand.. The shorts must and I mean have to know this too, why are they still in this war as if they still think they can bankrupt MNKD? Will they ever give up? When the news hits about partnering in other countries will they cover? Something tells me NO. Unfortunately they are a virus that will only have one cure, a pill of large script numbers to profitability. Then they will have no choice but to release there grip on this stock. Last week was very exciting and I went all in on Monday and Tuesday's premarket at .80 and 1.00 buys I'm holding till the shorts are gone and this reaches its full potential. The sky's the limit. Good luck. Exactly!
|
|
|
Post by golfeveryday on May 13, 2017 6:16:14 GMT -5
I believe you! There is just one thing I don't understand.. The shorts must and I mean have to know this too, why are they still in this war as if they still think they can bankrupt MNKD? Will they ever give up? When the news hits about partnering in other countries will they cover? Something tells me NO. Unfortunately they are a virus that will only have one cure, a pill of large script numbers to profitability. Then they will have no choice but to release there grip on this stock. Last week was very exciting and I went all in on Monday and Tuesday's premarket at .80 and 1.00 buys I'm holding till the shorts are gone and this reaches its full potential. The sky's the limit. Good luck. Exactly! Shorts are most likely hedged with calls and will only exit when forced to exit. Let's hope that milestone arrives soon. Until buyout, I do think there will always be a short position, but it would be nice for once if it wasn't so significant.
|
|
|
Post by nadathing on May 13, 2017 6:44:57 GMT -5
While middle eastern countries have a serious problem of diabetes, they have an even bigger problem with smoking. UAE is 30% smokers and for "young people" its upwards of 40%. Not only is the percentage very high, its growing higher in recent years. Rates of lung cancer are growing. Likely there is a population of ex-smokers too. Mnkd making another strategic blunder going into the middle east IMO. What other choice of countries do they have to start selling in? Al Mann said EU filing would occur right after US approval. I don't think it has been done even after 3 years from Approval. The whole thing stinks. IMO the market is juvenile diabetes and overseas. Too late for MNKD.
|
|
|
Post by peppy on May 13, 2017 7:03:29 GMT -5
We're a bit off stream topic but while so I have a fairly novice type question for some resident experts please. I know tough to say with the number of variables but does anyone have a guess as to what would be a "normal" % short for Mnkd or similar? Currently around 30% or so I believe. Should it be half that and what about naked shorts? And what about the methods used on Mnkd with the small rapid 100 share blocks to help drive price down, is this normal or far worse with Mnkd? If so why? Subjective opinion topic but just curious. So much talk about shorting but of course not enough relative context. Yahoo has short shares in statistics. finance.yahoo.com/quote/AAPL/key-statistics?p=AAPL AAPL, an uptrender, 5.2 billion shares. 52 million shares short = 1% float.
M a downtrender 6% shares short finance.yahoo.com/quote/M/key-statistics?p=M
|
|
|
Post by bioexec25 on May 13, 2017 7:09:55 GMT -5
Nada, I doubt UAE would be their first choice imo. For all the reasons a terabyte of posts have waxed eloquent this drug isn't in high demand and without a partner with resources, investment at home and abroad are minuscule. There was some deal that was likely cut and I guess we will find out. You'd think the company who will be distributing Afrezza would have done DD on the market for the ME. Maybe they hate needles or maybe it is targeting peds. Maybe it's a hub for other countries. Who knows at this point.
|
|
|
Post by promann on May 13, 2017 7:19:03 GMT -5
While middle eastern countries have a serious problem of diabetes, they have an even bigger problem with smoking. UAE is 30% smokers and for "young people" its upwards of 40%. Not only is the percentage very high, its growing higher in recent years. Rates of lung cancer are growing. Likely there is a population of ex-smokers too. Mnkd making another strategic blunder going into the middle east IMO. Good place to initiate and recruit for new clinical study to determine safeness and effectiveness among smokers. Also to determine safeness and effectiveness among children..
|
|
|
Post by peppy on May 13, 2017 7:30:16 GMT -5
Nada, I doubt UAE would be their first choice imo. For all the reasons a terabyte of posts have waxed eloquent this drug isn't in high demand and without a partner with resources, investment at home and abroad are minuscule. There was some deal that was likely cut and I guess we will find out. You'd think the company who will be distributing Afrezza would have done DD on the market for the ME. Maybe they hate needles or maybe it is targeting peds. Maybe it's a hub for other countries. Who knows at this point. Banging my head. This drug is in high demand. It has been shut down by the Physicians, who are reacting to? Insurance? The hell this drug isn't in high demand.
If I was a type one diabetic, and I had to take shots, that supposedly controlled my diabetes, so I have some strips, a meter and a couple of pens. I really do not know how terrible I feel anymore, and managing my huge problem means life or death.....
It is a real head banger.
In the meantime, physicians are prescribing every POS medication made by big pharma. I went on goodrx, some of the anticoagulants, so people do not have to be on warfarin any more cost as much per month as afrezza. Ditto the anti cholesterol medications.
Demand is here. "Remember Sweedee's Dad!"
|
|